Biohaven

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Biogen Idec

This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Cyclerion Therapeutics

This biopharmaceutical company develops neuropsychiatric therapies for patients with treatment-resistant depression and other neurodegenerative diseases.

Denali Therapeutics

This biopharmaceutical company develops medicines crossing the blood-brain barrier to treat patients with neurodegenerative diseases and lysosomal storage disorders.

Deciphera Pharmaceuticals

This biopharmaceutical company develops and commercialises kinase-inhibiting drugs for patients with cancer, immunological diseases, and neurological conditions.

Pheno Therapeutics

This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.